Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024

Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024 – By Treatment Type (Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy), By Mode of Administration (Injectables, Oral, Other Mode Of Administrations), By Application (Hospitals, Clinics, Other Applications) – Market Size, Trends, And Global Forecast 2024-2033

Name: Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024
Creator: The Business Research Company
License: https://www.thebusinessresearchcompany.com/privacy-policy

Proliferative Diabetic Retinopathy (PDR) Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Purchase Options

Request a Sample

Request For Discount

Customise Your Report

Item added to cart!

Request For Proposal

Request For Regional Data

FAQs

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

Proliferative Diabetic Retinopathy (PDR) Market Definition

Proliferative diabetic retinopathy (PDR) refers to an advanced stage of diabetic eye disease characterized by the growth of abnormal blood vessels in the retina due to prolonged high blood sugar levels. These vessels can lead to retinal bleeding, scarring and vision impairment if left untreated, making regular eye examinations crucial for early detection and management.

The main treatment types of proliferative diabetic retinopathy are anti-VEGF (vascular endothelial growth factor) therapy, intraocular steroids, laser surgery and vitrectomy. Intraocular steroids are medications administered directly into the eye to manage inflammation and treat conditions like diabetic macular edema or uveitis, helping reduce swelling and improve visual outcomes. The various mode of administration includes injectables, oral and others that are used by various applications such as hospitals, clinics and others.

Proliferative Diabetic Retinopathy (PDR) Market Segmentation

The proliferative diabetic retinopathy (pdr) market covered in this report is segmented –

1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy; Intraocular Steroids; Laser Surgery; Vitrectomy

2) By Mode of Administration: Injectables; Oral; Other Mode Of Administrations

3) By Application: Hospitals; Clinics; Other Applications

Global Proliferative Diabetic Retinopathy PDR Market Size 2023 to 2028: Graph

Proliferative Diabetic Retinopathy (PDR) Market Size 2024 And Growth Rate

The proliferative diabetic retinopathy (pdr) market size has grown rapidly in recent years. It will grow from $2.16 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growing diabetes prevalence, changes in lifestyle and intake of unhealthy foods, government initiatives, rising numbers of diabetes-related loss of vision.

Proliferative Diabetic Retinopathy (PDR) Market Growth Forecast

The proliferative diabetic retinopathy (pdr) market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to aging population, public awareness and education about diabetes, research and development funding, rising demand for combination therapies. Major trends in the forecast period include advancements in diagnostic technologies, innovations in treatment options, artificial intelligence (ai) for early diagnosis, gene therapy advancements, advanced retinal imaging.

Book your 30 minutes free consultation with our research experts

Proliferative Diabetic Retinopathy (PDR) Market Driver: Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market

The rising prevalence of diabetes is expected to propel the growth of the proliferative diabetic retinopathy (PDR) market going forward. Diabetes is a chronic medical condition characterized by elevated glucose (sugar) levels in the blood. Diabetes is the leading cause of proliferative diabetic retinopathy disease, which can be treated by various methods that prevent further damage to the retina and preserve vision. For instance, in 2021, according to the International Diabetes Federation (IDF), a Belgium-based organization, 537 million adults aged between 20-79 are suffering from diabetes (1 in 10 people) and this number is expected to reach about 643 million by 2030 and 783 million by 2045. Therefore, the rising prevalence of diabetes drives the proliferative diabetic retinopathy (PDR) market.

Proliferative Diabetic Retinopathy (PDR) Market Driver: Impact Of Obesity On Proliferative Diabetic Retinopathy (PDR) Market Growth

The rising incidence of obesity is anticipated to drive future expansion in the proliferative diabetic retinopathy (PDR) market. Obesity is a complex, chronic disease with several causes that lead to excessive body fat and sometimes, poor health. Obesity is associated with insulin resistance, chronic low-grade inflammation, and increased oxidative stress, which can damage the retinal microvasculature and contribute to the development of diabetic retinopathy. For instance, according to the 2022 report published by Trust for America's Health, a US-based non-profit organization, the obesity rates in the US continue to climb, with four in ten American adults having obesity. This is an increase from the previous year, with 19 states having adult obesity rates over 35%, up from 16 states last year. Hence, the growing prevalence of obesity is a driving force behind the expansion of the proliferative diabetic retinopathy (PDR) market.

Global Proliferative Diabetic Retinopathy (PDR) Market Major Players

Major players in the proliferative diabetic retinopathy (pdr) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc.

Global Proliferative Diabetic Retinopathy (PDR) Market Restraint: Impact Of High Treatment Costs On The Proliferative Diabetic Retinopathy (PDR) Market

The high treatment costs are restrain the proliferative diabetic retinopathy (PDR) market's growth during the forecast period. The cost of diagnosing and treating PDR can be prohibitively expensive. This includes the expenses associated with frequent eye examinations, laser therapy, and, in some cases, surgical interventions. High treatment costs can be a significant financial burden for both patients and healthcare systems. For instance, in 2023, according to Medical News Today, a medical news publisher, individuals typically incur annual management costs ranging from $600 to $1,000 for the treatment of diabetic eye disease, and the cost of a vitrectomy procedure falls within the range of $8,000 to $14,000. Therefore, high treatment costs are hindering the growth of the proliferative diabetic retinopathy (PDR) market.

Global Proliferative Diabetic Retinopathy (PDR) Market Trend: Innovative Therapies Revolutionize Proliferative Diabetic Retinopathy Treatment Landscape

Major companies operating in the proliferative diabetic retinopathy market continuously focus on developing novel therapies to enhance treatment effectiveness, reduce treatment burden and improve patient outcomes. For example, in June 2022, Biogen, a US-based biotechnology company and Samsung Bioepis, a South Korea-based biotech company, introduced Byooviz (ranibizumab-nuna), the first ophthalmology biosimilar in the US. These products are used to treat patients with diabetic macular edema, proliferative diabetic retinopathy, neovascular age-related macular degeneration (wet AMD) and choroidal neovascularization.

Proliferative Diabetic Retinopathy (PDR) Market Merger And Acquisition: Abbvie And Regenxbio Partner To Advance Rgx-314 Gene Therapy For Proliferative Diabetic Retinopathy And Wet Amd

In September 2021, AbbVie, a US-based pharmaceutical company, collaborated with REGENXBIO Inc. for an undisclosed amount. Through this partnership, both companies aim to develop and market RGX-314, a potential one-time gene therapy designed to address wet age-related macular degeneration (wet AMD), diabetic retinopathy (DR) and other chronic retinal diseases. RGX-314 is currently undergoing assessment in a pivotal trial for wet AMD, utilizing subretinal administration and in separate Phase II clinical trials for wet AMD and DR, employing in-office suprachoroidal delivery. REGENXBIO Inc. is a US-based company that develops treatments for proliferative diabetic retinopathy (PDR).

Regional Outlook For The Global Proliferative Diabetic Retinopathy (PDR) Market

North America was the largest region in the proliferative diabetic retinopathy market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the proliferative diabetic retinopathy (PDR) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The proliferative diabetic retinopathy (PDR) market consists of sales of laser therapy, systemic therapies and combination therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The proliferative diabetic retinopathy (PDR) market also includes sales of corticosteroids, ranibizumab, bevacizumab and fluocinolone acetonide drugs. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The proliferative diabetic retinopathy market research report is one of a series of new reports from The Business Research Company that provides proliferative diabetic retinopathy market statistics, including proliferative diabetic retinopathy industry global market size, regional shares, competitors with a proliferative diabetic retinopathy market share, detailed proliferative diabetic retinopathy market segments, market trends and opportunities and any further data you may need to thrive in the proliferative diabetic retinopathy industry. This proliferative diabetic retinopathy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Proliferative Diabetic Retinopathy (PDR) Market Report Scope

Report Attribute	Details
Market Size Value In 2024	$2.42 billion
Revenue Forecast In 2033	$3.62 billion
Growth Rate	CAGR of 10.6% from 2024 to 2033
Base Year For Estimation	2023
Actual Estimates/Historical Data	2018-2023
Forecast Period	2024 - 2028 - 2033
Market Representation	Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered	1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy 2) By Mode of Administration: Injectables, Oral, Other Mode Of Administrations 3) By Application: Hospitals, Clinics, Other Applications
Regional Scope	Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled	Pfizer Inc.; Johnson and Johnson Limited; F. Hoffmann-La Roche Ltd.; Merck and Co. Inc.; AbbVie Inc.; Bayer AG; Novartis AG; Sanofi S.A.; Bristol-Myers Squibb Company; AstraZeneca plc; GSK plc; Takeda Pharmaceutical Company Limited; Eli Lilly and Company; Amgen Inc.; Novo Nordisk A/S; Boehringer Ingelheim International GmbH; Merck KGaA; Kubota Vision Inc.; Teva Pharmaceutical Industries Ltd.; Regeneron Pharmaceuticals Inc.; Mylan N.V.; Santen Pharmaceutical Co. Ltd.; Lupin Limited; Genentech Inc.; Sirnaomics Inc.
Customization Scope	Request for Sample
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

2. Proliferative Diabetic Retinopathy (PDR) Market Characteristics

3. Proliferative Diabetic Retinopathy (PDR) Market Trends And Strategies

4. Proliferative Diabetic Retinopathy (PDR) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market

4.2. Ukraine-Russia War Impact On The Market

4.3. COVID-19 Impact On The Market

5. Global Proliferative Diabetic Retinopathy (PDR) Market Size and Growth

5.1. Global Proliferative Diabetic Retinopathy (PDR) Market Drivers and Restraints

5.1.1. Drivers Of The Market

5.1.2. Restraints Of The Market

5.2. Global Proliferative Diabetic Retinopathy (PDR) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

5.3. Global Proliferative Diabetic Retinopathy (PDR) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Proliferative Diabetic Retinopathy (PDR) Market Segmentation

6.1. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Anti-VEGF (Vascular Endothelial Growth Factor) Therapy

Intraocular Steroids

Laser Surgery

Vitrectomy

6.2. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Injectables

Oral

Other Mode Of Administrations

6.3. Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Hospitals

Clinics

Other Applications

7. Proliferative Diabetic Retinopathy (PDR) Market Regional And Country Analysis

7.1. Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

7.2. Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market

8.1. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market Overview

Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.3. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8.4. Asia-Pacific Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Proliferative Diabetic Retinopathy (PDR) Market

9.1. China Proliferative Diabetic Retinopathy (PDR) Market Overview

9.2. China Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.3. China Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

9.4. China Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Proliferative Diabetic Retinopathy (PDR) Market

10.1. India Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.2. India Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

10.3. India Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Proliferative Diabetic Retinopathy (PDR) Market

11.1. Japan Proliferative Diabetic Retinopathy (PDR) Market Overview

11.2. Japan Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.3. Japan Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11.4. Japan Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Proliferative Diabetic Retinopathy (PDR) Market

12.1. Australia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.2. Australia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12.3. Australia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Proliferative Diabetic Retinopathy (PDR) Market

13.1. Indonesia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.2. Indonesia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13.3. Indonesia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Proliferative Diabetic Retinopathy (PDR) Market

14.1. South Korea Proliferative Diabetic Retinopathy (PDR) Market Overview

14.2. South Korea Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.3. South Korea Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14.4. South Korea Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Proliferative Diabetic Retinopathy (PDR) Market

15.1. Western Europe Proliferative Diabetic Retinopathy (PDR) Market Overview

15.2. Western Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.3. Western Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15.4. Western Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Proliferative Diabetic Retinopathy (PDR) Market

16.1. UK Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.2. UK Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16.3. UK Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Proliferative Diabetic Retinopathy (PDR) Market

17.1. Germany Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.2. Germany Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17.3. Germany Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Proliferative Diabetic Retinopathy (PDR) Market

18.5. France Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.6. France Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18.7. France Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Proliferative Diabetic Retinopathy (PDR) Market

19.9. Italy Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.10. Italy Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19.11. Italy Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Proliferative Diabetic Retinopathy (PDR) Market

20.13. Spain Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.14. Spain Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20.15. Spain Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market

21.1. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market Overview

21.2. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.3. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21.4. Eastern Europe Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Proliferative Diabetic Retinopathy (PDR) Market

22.1. Russia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.2. Russia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22.3. Russia Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Proliferative Diabetic Retinopathy (PDR) Market

23.1. North America Proliferative Diabetic Retinopathy (PDR) Market Overview

23.2. North America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.3. North America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23.4. North America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Proliferative Diabetic Retinopathy (PDR) Market

24.1. USA Proliferative Diabetic Retinopathy (PDR) Market Overview

24.2. USA Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.3. USA Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24.4. USA Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Proliferative Diabetic Retinopathy (PDR) Market

25.1. Canada Proliferative Diabetic Retinopathy (PDR) Market Overview

25.2. Canada Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.3. Canada Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25.4. Canada Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Proliferative Diabetic Retinopathy (PDR) Market

26.1. South America Proliferative Diabetic Retinopathy (PDR) Market Overview

26.2. South America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.3. South America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26.4. South America Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Proliferative Diabetic Retinopathy (PDR) Market

27.1. Brazil Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.2. Brazil Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27.3. Brazil Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Proliferative Diabetic Retinopathy (PDR) Market

28.1. Middle East Proliferative Diabetic Retinopathy (PDR) Market Overview

28.2. Middle East Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.3. Middle East Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28.4. Middle East Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Proliferative Diabetic Retinopathy (PDR) Market

29.1. Africa Proliferative Diabetic Retinopathy (PDR) Market Overview

29.2. Africa Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.3. Africa Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29.4. Africa Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Proliferative Diabetic Retinopathy (PDR) Market Competitive Landscape And Company Profiles

30.1. Proliferative Diabetic Retinopathy (PDR) Market Competitive Landscape

30.2. Proliferative Diabetic Retinopathy (PDR) Market Company Profiles

30.2.1. Pfizer Inc.

30.2.1.1. Overview

30.2.1.2. Products and Services

30.2.1.3. Strategy

30.2.1.4. Financial Performance

30.2.2. Johnson and Johnson Limited

30.2.2.1. Overview

30.2.2.2. Products and Services

30.2.2.3. Strategy

30.2.2.4. Financial Performance

30.2.3. F. Hoffmann-La Roche Ltd.

30.2.3.1. Overview

30.2.3.2. Products and Services

30.2.3.3. Strategy

30.2.3.4. Financial Performance

30.2.4. Merck and Co. Inc.

30.2.4.1. Overview

30.2.4.2. Products and Services

30.2.4.3. Strategy

30.2.4.4. Financial Performance

30.2.5. AbbVie Inc.

30.2.5.1. Overview

30.2.5.2. Products and Services

30.2.5.3. Strategy

30.2.5.4. Financial Performance

31. Proliferative Diabetic Retinopathy (PDR) Market Other Major And Innovative Companies

31.1. Bayer AG

31.2. Novartis AG

31.3. Sanofi S.A.

31.4. Bristol-Myers Squibb Company

31.5. AstraZeneca plc

31.6. GSK plc

31.7. Takeda Pharmaceutical Company Limited

31.8. Eli Lilly and Company

31.9. Amgen Inc.

31.10. Novo Nordisk A/S

31.11. Boehringer Ingelheim International GmbH

31.12. Merck KGaA

31.13. Kubota Vision Inc.

31.14. Teva Pharmaceutical Industries Ltd.

31.15. Regeneron Pharmaceuticals Inc.

32. Global Proliferative Diabetic Retinopathy (PDR) Market Competitive Benchmarking

33. Global Proliferative Diabetic Retinopathy (PDR) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Proliferative Diabetic Retinopathy (PDR) Market

35. Proliferative Diabetic Retinopathy (PDR) Market Future Outlook and Potential Analysis

35.1 Proliferative Diabetic Retinopathy (PDR) Market In 2028 - Countries Offering Most New Opportunities

35.2 Proliferative Diabetic Retinopathy (PDR) Market In 2028 - Segments Offering Most New Opportunities

35.3 Proliferative Diabetic Retinopathy (PDR) Market In 2028 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Historic Market Growth, 2018-2023, $ Billion

Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Table 3: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 4: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 5: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 6: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 7: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 8: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 9: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 10: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 11: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 12: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 13: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 14: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 15: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 16: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 17: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 18: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 19: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 20: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 21: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 22: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 23: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 24: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 25: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 26: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 27: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 28: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 29: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 30: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 31: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 32: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 33: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 34: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 35: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 36: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 37: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 38: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 39: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 40: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 41: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 42: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 43: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 44: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 45: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 46: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 47: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 48: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 49: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 50: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 51: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 52: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 53: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 54: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 55: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 56: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 57: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 58: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 59: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 60: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 61: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 62: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 63: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 64: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 65: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 66: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 67: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 68: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 69: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 70: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 71: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 72: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 73: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Table 74: Pfizer Inc. Financial Performance

Table 75: Johnson and Johnson Limited Financial Performance

Table 76: F. Hoffmann-La Roche Ltd. Financial Performance

Table 77: Merck and Co. Inc. Financial Performance

Table 78: AbbVie Inc. Financial Performance

List Of Figures

Figure 1: Global Historic Market Growth, 2018-2023, $ Billion

Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion

Figure 3: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 4: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 5: Global Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 6: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 7: Global Proliferative Diabetic Retinopathy (PDR) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 8: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 9: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 10: Asia-Pacific, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 11: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 12: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 13: China, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 14: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 15: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 16: India, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 17: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 18: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 19: Japan, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 20: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 21: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 22: Australia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 23: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 24: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 25: Indonesia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 26: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 27: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 28: South Korea, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 29: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 30: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 31: Western Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 32: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 33: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 34: UK, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 35: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 36: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 37: Germany, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 38: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 39: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 40: France, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 41: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 42: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 43: Italy, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 44: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 45: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 46: Spain, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 47: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 48: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 49: Eastern Europe, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 50: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 51: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 52: Russia, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 53: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 54: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 55: North America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 56: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 57: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 58: USA, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 59: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 60: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 61: Canada, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 62: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 63: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 64: South America, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 65: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 66: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 67: Brazil, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 68: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 69: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 70: Middle East, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 71: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 72: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Mode of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 73: Africa, Proliferative Diabetic Retinopathy (PDR) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

Figure 74: Pfizer Inc. Financial Performance

Figure 75: Johnson and Johnson Limited Financial Performance

Figure 76: F. Hoffmann-La Roche Ltd. Financial Performance

Figure 77: Merck and Co. Inc. Financial Performance

Figure 78: AbbVie Inc. Financial Performance

Forecasting Till 2030: Opportunities And Strategies In The Global Value Based Care Payment Market – Includes Value Based Care Payment Market Analysis

How Will The Nuclear Medicine Market Grow In 2022?

What Is The Pediatric Imaging Market Overview In 2022?

Latest Healthcare Technology Management Market Growth Study 2022-2026 By The Business Research Company

The Business Research Company offers the renal biomarkers market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the rcm market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the medical tourism market research report 2022 with industry size, share, segments and market growth

The Business Research Company offers the clinical chemistry market market research report 2022 with industry size, share, segments and market growth

Pet Diabetes Care Global Market Report 2024 – By Drug Type( Insulin Therapy, Oral Medication ), By Device Type( Glucose Monitoring Devices, Insulin Delivery Devices ), By Animal Type( Canine, Feline, Other Animal Types ), By End-User( Veterinary Clinics, Home Care Settings, Veterinary Hospitals) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Pet Diabetes Care Devices Global Market Report 2024 – By Animal Type (Dogs, Cats, Horses ), By Device (Glucose Monitoring Devices, Insulin Delivery Devices ), By End Users (Homecare, Veterinary Hospitals, Others End Users ) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Artificial Intelligence in Diabetes Management Global Market Report 2024 – By Device (Diagnostic Devices, Glucose Monitoring Devices, Insulin Delivery Devices, Other Devices), By Techniques (Case-Based Reasoning, Intelligent Data Analysis), By End-Use (Hospitals, Clinics, Home Care Settings, Research Institutes) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Digital Diabetes Management Global Market Report 2024 – By Product & Service (Devices, Application, Data Management Software & Platforms, Services), By Device Type (Handheld Devices, Wearable Devices), By End User (Self/Home Healthcare, Hospitals & Specialty Diabetes Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Insulin Drugs Global Market Report 2024 – By Product Type (Basal Or Long-Acting Insulins, Bolus Or Fast-Acting Insulins, Pre-Mixed, And Intermediate And Short Acting Insulins), By Source Type (Insulin Analogs, And Human Insulin), By Drug Classification (Branded Drugs, And Generic Drugs), By Application (Type 2 Diabetes, Type 1 Diabetes, And Gestational Diabetes), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, And Online) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Smart Insulin Pens Global Market Report 2024 – By Type (First Generation Pens, Second Generation Pens), By Usability (Prefilled, Reusable), By Application (Type 1 Diabetes, Type 2 Diabetes), By End User (Hospitals & Clinics, Ambulatory Surgical Centres, Home Care Settings) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Diabetes Care Devices Global Market Report 2024 – By Type (Blood Glucose Test Strips, Insulin Pens, Syringes, Pumps And Injectors, Lancing Devices And Equipment, Continuous Glucose Monitoring Devices And Equipment, Blood Glucose Meter), By Type of Expenditure (Public, Private), By Product (Instruments/Equipment, Disposables), By Type Of Testing (Point Of Care (POC) Testing, Non-Point Of Care (POC) Testing), By End User (Hospitals And Clinics, Diagnostic Laboratories, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Insulin Pens, Syringes, Pumps And Injectors Global Market Report 2024 – By Type (Pens, Injectors And Pumps, Syringes), By Pens (Reusable, Disposable), By Pumps (Tubed Pumps, Tubeless Pumps), By End Users (Hospitals, Homecare, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

View Report

Frequently Asked Questions

What is the definition of the proliferative diabetic retinopathy (PDR) market?

How will the proliferative diabetic retinopathy (PDR) market drivers and restraints affect the proliferative diabetic retinopathy (PDR) market dynamics? What forces will shape the proliferative diabetic retinopathy (PDR) industry going forward?

The proliferative diabetic retinopathy (PDR) market major growth driver - Rising Diabetes Prevalence Boosts Growth In The Proliferative Diabetic Retinopathy (PDR) Market. request a sample here

What is the forecast market size or the forecast market value of the proliferative diabetic retinopathy (PDR) market?

The proliferative diabetic retinopathy (PDR) market size has grown rapidly in recent years. It will grow from $2.16 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 11.7%. The growth in the historic period can be attributed to growing diabetes prevalence, changes in lifestyle and intake of unhealthy foods, government initiatives, rising numbers of diabetes-related loss of vision. The proliferative diabetic retinopathy (PDR) market size is expected to see rapid growth in the next few years. It will grow to $3.62 billion in 2028 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to aging population, public awareness and education about diabetes, research and development funding, rising demand for combination therapies. Major trends in the forecast period include advancements in diagnostic technologies, innovations in treatment options, artificial intelligence (ai) for early diagnosis, gene therapy advancements, advanced retinal imaging. request a sample here

How is the proliferative diabetic retinopathy (PDR) market segmented?

The proliferative diabetic retinopathy (PDR) market is segmented
1) By Treatment Type: Anti-VEGF (Vascular Endothelial Growth Factor) Therapy, Intraocular Steroids, Laser Surgery, Vitrectomy
2) By Mode of Administration: Injectables, Oral, Other Mode Of Administrations
3) By Application: Hospitals, Clinics, Other ApplicationsFor further insights on the proliferative diabetic retinopathy (PDR) market request a sample here

Which region has the largest share of the proliferative diabetic retinopathy (PDR) market? What are the other regions covered in the report?

North America was the largest region in the proliferative diabetic retinopathy market in 2023. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in proliferative diabetic retinopathy (PDR) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa. request a sample here.

Who are the major players in the proliferative diabetic retinopathy (PDR) market?

Major players in the proliferative diabetic retinopathy (PDR) market are Pfizer Inc., Johnson and Johnson Limited, F. Hoffmann-La Roche Ltd., Merck and Co. Inc., AbbVie Inc., Bayer AG, Novartis AG, Sanofi S.A., Bristol-Myers Squibb Company, AstraZeneca PLC, GSK PLC, Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Boehringer Ingelheim International GmbH, Merck KGaA, Kubota Vision Inc., Teva Pharmaceutical Industries Ltd., Regeneron Pharmaceuticals Inc., Mylan N.V., Santen Pharmaceutical Co. Ltd., Lupin Limited, Genentech Inc., Sirnaomics Inc. request a sample here.

What are the key trends in the proliferative diabetic retinopathy (PDR) market?

Major trend in the proliferative diabetic retinopathy (PDR) market - Innovative Therapies Revolutionize Proliferative Diabetic Retinopathy Treatment Landscape. request a sample here.

What are the major opportunities in the proliferative diabetic retinopathy (PDR) market? What are the strategies for the proliferative diabetic retinopathy (PDR) market?

For detailed insights on the major opportunities and strategies in the proliferative diabetic retinopathy (PDR) market, request a sample here.

How does the proliferative diabetic retinopathy (PDR) market relate to the overall economy and other similar markets?

For detailed insights on proliferative diabetic retinopathy (PDR) market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the proliferative diabetic retinopathy (PDR) industry?

For detailed insights on the mergers and acquisitions in the proliferative diabetic retinopathy (PDR) industry, request a sample here.

What are the key dynamics influencing the proliferative diabetic retinopathy (PDR) market growth? SWOT analysis of the proliferative diabetic retinopathy (PDR) market.

For detailed insights on the key dynamics influencing the proliferative diabetic retinopathy (PDR) market growth and SWOT analysis of the proliferative diabetic retinopathy (PDR) industry, request a sample here.